Objective. To investigate whether patients' altered body composition (measured with bioimpedentiometry), due to a poor nutritional status, predicts the incidence of no residual disease at primary debulking and the risk of complications in patients with newly-diagnosed advanced epithelial ovarian cancer (EOC).Methods. Data regarding patients with newly-diagnosed stage IIIC-IV EOC undergoing elective nutritional assessment between December 2016 and March 2017, were prospectively collected. Bioelectrical impedance analysis (BIA) with measurement of BIA-derived phase angle [PM] at 50 KHz, was accomplished. Only patients with disease which was considered resectable at staging laparoscopy were submitted to open primary cytoreduction. The rate of residual tumor (RT) = 0 and the incidence of complications were assessed.Results. Seventy patients were included. Fifty-two of them were submitted to primary cytoreduction (74.3%) and 48 (68.6% of the entire cohort, 92.3% of those who underwent primary debulking) had RT = 0 at the end of surgery. Median values of PM were significantly lower in patients with RT > vs. =0 (4.7, range: 3.6-5.8 vs. 53, range: 4.2-6.8; p = 0.001). Twenty-four (out of the 52 operated) patients (462%) developed at least one complication. PhA was significantly lower in patients with vs. without complications (5, range: 3.6-6.4, vs. 5.4, range 4.5-6.8; p = 0.03). After multivariable analysis, Fagotti score and PM were the only independent predictors of residual disease (OR:13.56; 95%0:1.33-137.6; p = 0.027 and 924; 1.16-73.43; p = 0.036, respectively) and of any complication (OR:4.9;95%CI:1.17-20.6; p = 0.03 and 7.27; 1.45-36.4; p = 0.01, respectively).Conclusions. Derangement of body composition (likely due to disease-related malnutrition) expressed as a low phase angle, is an independent predictor of residual disease and peri-operative complications at the time of upfront cytoreduction for advanced EOC. (C) 2018 Elsevier Inc. All rights reserved.
Assessment of preoperative nutritional status using {BIA}-derived phase angle ({PhA}) in patients with advanced ovarian cancer: Correlation with the extent of cytoreduction and complications
Stefano Uccella;
2018-01-01
Abstract
Objective. To investigate whether patients' altered body composition (measured with bioimpedentiometry), due to a poor nutritional status, predicts the incidence of no residual disease at primary debulking and the risk of complications in patients with newly-diagnosed advanced epithelial ovarian cancer (EOC).Methods. Data regarding patients with newly-diagnosed stage IIIC-IV EOC undergoing elective nutritional assessment between December 2016 and March 2017, were prospectively collected. Bioelectrical impedance analysis (BIA) with measurement of BIA-derived phase angle [PM] at 50 KHz, was accomplished. Only patients with disease which was considered resectable at staging laparoscopy were submitted to open primary cytoreduction. The rate of residual tumor (RT) = 0 and the incidence of complications were assessed.Results. Seventy patients were included. Fifty-two of them were submitted to primary cytoreduction (74.3%) and 48 (68.6% of the entire cohort, 92.3% of those who underwent primary debulking) had RT = 0 at the end of surgery. Median values of PM were significantly lower in patients with RT > vs. =0 (4.7, range: 3.6-5.8 vs. 53, range: 4.2-6.8; p = 0.001). Twenty-four (out of the 52 operated) patients (462%) developed at least one complication. PhA was significantly lower in patients with vs. without complications (5, range: 3.6-6.4, vs. 5.4, range 4.5-6.8; p = 0.03). After multivariable analysis, Fagotti score and PM were the only independent predictors of residual disease (OR:13.56; 95%0:1.33-137.6; p = 0.027 and 924; 1.16-73.43; p = 0.036, respectively) and of any complication (OR:4.9;95%CI:1.17-20.6; p = 0.03 and 7.27; 1.45-36.4; p = 0.01, respectively).Conclusions. Derangement of body composition (likely due to disease-related malnutrition) expressed as a low phase angle, is an independent predictor of residual disease and peri-operative complications at the time of upfront cytoreduction for advanced EOC. (C) 2018 Elsevier Inc. All rights reserved.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
